Hdac3 is essential for efficient DNA replication and DNA damage control. Deletion of Hdac3 impaired DNA repair and greatly reduced chromatin compaction and heterochromatin content. These defects corresponded to increases in histone H3K9,K14ac; H4K5ac; and H4K12ac in late S phase of the cell cycle, and histone deposition marks were retained in quiescent Hdac3-null cells. Liver-specific deletion of Hdac3 culminated in hepatocellular carcinoma. Whereas HDAC3 expression was downregulated in only a small number of human liver cancers, the mRNA levels of the HDAC3 cofactor NCOR1 were reduced in one-third of these cases. siRNA targeting of NCOR1 and SMRT (NCOR2) increased H4K5ac and caused DNA damage, indicating that the HDAC3/NCOR/SMRT axis is critical for maintaining chromatin structure and genomic stability.
INTRODUCTION
Histone deacetylases (HDACs) play major roles in modulating chromatin accessibility during transcription, replication, recombination, and repair (Gallinari et al., 2007; Goodarzi et al., 2009 ), yet the role of individual HDACs in these processes is still unclear. Deacetylation of histones is required for re-establishing chromatin structure on a local basis after transcription of a gene or after the repair of a DNA double-strand break (Tsukamoto et al., 1997) . On a global scale, HDACs act during DNA replication when the cellular histone content is doubled, as these newly synthesized histones are acetylated prior to their deposition onto nascent DNA. The residues most commonly associated with this process are H4K5ac and H4K12ac (Sobel et al., 1995; Taddei et al., 1999) . These modifications presumably allow histone chaperones to configure the nucleosome correctly before deacetylation stabilizes the nucleosome and/or allows higher-order compaction of the chromatin and the formation of Significance Broad-spectrum histone deacetylase inhibitors (HDI) are being used to treat a variety of cancers, and more selective inhibitors are being developed for therapeutic uses. Genetic analysis of individual histone deacetylases (HDACs) is essential to understand the action of these inhibitors and their potential side effects. We show that inactivation of Hdac3, a central target of all currently used HDIs, causes genomic instability, and deletion of Hdac3 in the liver leads to hepatocellular carcinoma. These phenotypes correlate with global increases in the acetylation of specific histone residues, disruptions in chromatin structure, and a loss of heterochromatin. Our results genetically link the HDAC3/NCOR/SMRT axis to the maintenance of critical cell-cycle functions and genomic stability.
heterochromatin (Luger et al., 1997; Luger and Richmond, 1998; Neumann et al., 2009; Verreault et al., 1996) . This process of histone acetylation/deacetylation is required for genomic stability and cell viability, as perturbations in the acetyltransferase or components of this pathway cause genomic instability and result in a failure to recover from genotoxic stress (Clarke et al., 1999; Han et al., 2007; Smith et al., 1998; Yuan et al., 2009 ). This is a dynamic process that occurs across the entire genome, and the role of HDACs in the re-establishment of chromatin structure after replication is one of the least explored areas of their action. As such, genetic methods have been the most informative approaches to understand the physiological role of these critical regulatory enzymes.
Targeting enzymes that control chromatin structure and topography has been an extremely valuable tool in cancer therapy. A wide variety of general and specific small-molecule inhibitors targeted toward HDACs are currently in clinical trials and are used as therapies for both solid and hematological tumors (Bolden et al., 2006) . At therapeutic doses, histone deacetylase inhibitors (HDIs) not only cause cell-cycle-dependent DNA damage but also affect DNA repair, which sensitizes cells to ionizing radiation (IR), topoisomerase inhibitors, and cisplatin (Baschnagel et al., 2009; Marchion et al., 2004; Suzuki et al., 2009 ). However, the molecular mechanism for inefficient DNA repair following HDI treatment is still not clear. Given the high levels of histone acetylation that accumulate in the context of these inhibitors, it is reasonable to assume that disruption of chromatin structure may contribute to cell death. As more selective HDAC inhibitors are moving into clinical trials, it is important to elucidate the function of individual HDACs to design better and more specific drugs for cancer therapy and to understand the mechanism(s) of action or side effects.
Hdac3, a class I HDAC, associates with the nuclear hormone corepressors NCOR and SMRT (Codina et al., 2005) and is generally thought of as a locus-specific corepressor that is recruited to promoters to repress genes regulated by nuclear hormone receptors and other transcription factors (Jones and Shi, 2003) . In yeast, Snt1 and Hos2 have features of NCOR/ SMRT and Hdac3, respectively (Pijnappel et al., 2001 ). This suggests a more ancestral and fundamental role of these proteins perhaps in the cell cycle, and that this machinery is also used for gene-specific transcriptional regulation. In agreement with this hypothesis, conditional deletion of Hdac3 in mouse models demonstrated that murine embryonic fibroblasts (MEFs) required Hdac3 for cell viability . The observed apoptosis was associated with an impaired S phase progression and DNA double-strand breaks, rather than altered transcriptional programs . The DNA damage was blocked when cells were taken out of the cell cycle by serum starvation, which suggested that Hdac3 acts during the S phase . We propose that the cell-cycle functions of HDAC3 and its regulatory factors NCOR and SMRT may be the ancestral role and that disruption of these cell-cycle functions may have dramatic consequences for the regulation of chromatin structure and genomic stability. These roles may impact the usefulness of HDAC3 as a therapeutic target in cancer and other diseases.
RESULTS

Hdac3 Function Is Required for Efficient DNA Repair
The inactivation of Hdac3 resulted in increased sensitivity of quiescent MEFs to ionizing radiation, suggesting a defect predominantly in nonhomologous end joining (NHEJ)-mediated repair in these cells . To test whether these defects were due to altered DNA repair functions or due to altered histone modifications and the ensuing changes in chromatin structure, we examined whether the inactivation of Hdac3 increases the sensitivity of (Swift et al., 2006) and triggers S phase-associated DNA double-strand breaks that are repaired by the homologous recombination (HR) pathway, whereas cisplatin crosslinks DNA to form intrastrand adducts (Siddik, 2003) . Inactivation of Hdac3 increased the sensitivity of MEFs to doxorubicin ( Figure 1A ) and cisplatin ( Figure 1B ), suggesting that in the absence of Hdac3, these DNA repair pathways are inefficient. Given that Hdac3 deletion appeared to affect two independent types of DNA repair, we examined whether Hdac3 plays a role in the two major NHEJ and HR double-strand-break repair pathways. We employed a chromosomally integrated reporter allele system established in HEK293 cells (Figures 1C and 1D) and used siRNAs to deplete the endogenous levels of HDAC3 ( Figure 1E ) prior to cutting the reporter site with the I-Sce1 homing endonuclease. The efficiency of rejoining I-Sce1-cleaved sites was measured using quantitative PCR for NHEJ and by flow cytometry for reconstituted GFP expression for HR. In both cases, the reduction in Hdac3 levels caused a 50%-60% decrease in DNA repair (Figures 1F and 1G) , indicating that Hdac3 is essential for efficient NHEJ-and HR-mediated repair.
Although Hdac3 has been linked to NHEJ due to its association with the SMRT/Ku70 complex (Yu et al., 2006) , our DNA damage sensitivity and repair data suggested that Hdac3 loss affects DNA repair by targeting an element that is common to multiple types of DNA repair. Moreover, Hdac3 is not recruited to the sites of double-strand breaks following IR treatment (see Figure S1 available online), nor did its loss affect the localization of other members of the DNA damage response (Rad50, Brca1, Mdc1, and Mre11; data not shown). One of the key histone modifications that contributes to the DNA damage response, the first step in double-strand-break repair, is H3K9 trimethylation (H3K9me3), which recruits the histone acetyltransferase Tip60 (Sun et al., 2009 ) and other factors involved in the damage response (e.g., HP1b; Ayoub et al., 2008 ). Therefore, we tested whether siRNA targeting of HDAC3 would alter histone acetylation at the site of an integrated reporter. Chromatin immunoprecipitation employing anti-H3K9,K14ac showed that histone acetylation was increased at the substrate locus at a level consistent with global changes in H3K9,K14ac (see below), along with a concomitant decrease in H3K9me3 ( Figure 1H ), suggesting that global changes in histone modifications could contribute to the defects in DNA repair.
Inactivation of Hdac3 Alters Chromatin Structure and Decreases Global Heterochromatin
H3K9me3 is one of the best marks of heterochromatin. The decrease in H3K9me3 upon siRNA-mediated suppression of HDAC3 or Hdac3 deletion in the liver ( Figure 1H ; see below) prompted us to use the Albumin-Cre transgene to delete Hdac3 in vivo to examine chromatin structure. Initially, we used transmission electron microscopy to examine the nuclei from Alb-Cre:Hdac3 +/À and Alb-Cre:Hdac3 À/À postnatal day 17 (p17) livers ( Figure 2A ). As expected, in control nuclei the electron-dense heterochromatin was found at the nuclear periphery ( Figure 2A ). In contrast, Alb-Cre:Hdac3 À/À p17 liver nuclei showed a significant decrease in the amount of heterochromatin, especially at the periphery (Figure 2A ; note that the residual electron-dense material remaining is consistent with the presence of nucleoli). A similar result was obtained by enumerating the liver nuclei showed significantly fewer foci ( Figure 2B ). Moreover, when cell fractionation was used to isolate chromatin, immunoblot analysis demonstrated that Alb-Cre:Hdac3 À/À hepatocytes contained roughly 2-fold less HP1b on chromatin ( Figure 2C ). At the gene-specific level, we used chromatin immunoprecipitation to examine H3K9,K14ac at the p53 locus (Su et al., 2009 ). Inactivation of Hdac3 caused the accumulation of acetylated H3K9,K14 at the promoter, upstream of the promoter, within intron 1, and within the body of the gene ( Figure S1 ), which is consistent with global changes in chromatin structure and histone modifications. Thus, Hdac3 is required for maintaining chromatin structure in vivo.
Given the reduction in heterochromatin, we used micrococcal nuclease (MNase) digestion to examine nucleosomal compaction. Digestion of isolated nuclei with increasing concentrations of MNase demonstrated that the bulk chromatin from Hdac3 À/À hepatocytes was more sensitive to MNase digestion when compared to the chromatin from control hepatocytes ( Figure 2D ), indicating that global chromatin structure was altered and is more ''open'' in the absence of Hdac3. In addition, we noted that the amount of DNA associated with mononucleosomes did not increase with increasing concentrations of MNase, suggesting that the nucleosomal DNA was more accessible in the absence of Hdac3. Southern blot analysis of these same samples using major and minor satellite probes or quantitative PCR for these regions showed modest sensitivity without a change in nucleosomal spacing ( Figure S2 ) (Gilbert and Allan, 2001; Sugimura et al., 2010) . Given the apparent sensitivity of mononucleosomal DNA to MNase ( Figure 2D ), we tested the sensitivity of nucleosomes to ionic conditions by extracting histones with differing concentrations of salt. Consistent with prior results (Li et al., 1993) , histone H3 was resistant to NaCl concentrations up to 1.2 M in control hepatocytes, but in the absence of Hdac3, histone H3 was nearly completely soluble in 900 mM NaCl, suggesting that nucleosome integrity was altered in Hdac3 À/À hepatocytes.
Structural determinations of the nucleosome show that the basic lysine residues in histone tails can potentially associate with DNA, but more likely mediate contacts with acidic surfaces on adjacent nucleosomes to allow nucleosome compaction and fiber formation (Luger et al., 1997; Luger and Richmond, 1998; Schalch et al., 2005) . Therefore, we performed western blot analysis of nuclear extracts prepared from Alb-Cre:Hdac3
À/À p17 livers to examine global histone acetylation and methylation marks that neutralize the lysine charges and that regulate chromatin structure. Hdac3 deacetylates H4K5ac and H4K12ac in vitro (Johnson et al., 2002) , and loss of Hdac3 resulted in an accumulation of H4K5ac, H4K12ac, and H4K16ac, as well as H3K9,K14ac, with little effect on the acetylation of other residues ( Figure 3 ) . Examination of histone methylation demonstrated that H3K9me3 ) and H3K79me2 were reduced (Figure 3 ), whereas H3K4me3, H3K27me3, and H4K20me2 were unaffected (Figure 3 ). H4K5ac and H4K12ac are commonly associated with histone deposition onto newly synthesized DNA. Given that hepatocytes are generally quiescent, our liver-specific deletion of Hdac3 implies that Hdac3 is required for removing these marks during or after DNA synthesis. Therefore, we used Hdac3 The graph at the right shows quantification of foci from at least 100 cells for each sample expressed as the mean ± SEM. (C) HP1b localization to chromatin is reduced in Hdac3-null livers. Chromatincontaining fractions were isolated by cell fractionation, and whole-cell lysates (WCL) or chromatin fractions (Chrom.) were assessed using immunoblot analysis for HP1b, or histone H3 or b-actin as loading controls. Graph shows quantification of the ratio of HP1b to H3 on chromatin from three independent experiments expressed as the mean ± SEM. Figure S2 .
released into the cell cycle by the addition of serum to the culture medium. The level of H4K5ac and H4K12ac was then examined using western blot analysis of extracts prepared from cells at various time points after serum addition. After 48 hr of culture in the absence of serum, the percentage of cells in G 0 /G 1 approached 90% ( Figure S3 ) and H4K5ac and H4K12ac were reduced to low levels in control cells but remained high in Hdac3-depleted cells ( Figure 4A ). After serum addition, both cultures re-entered the cell cycle, with cells beginning to enter S phase at 12 hr and over 50% of the cells progressing through S phase by 18 hr as measured by BrdU incorporation ( Figure S3 ). At 18 and 24 hr after serum addition, H4K5ac and H4K12ac increased in the control cells, consistent with the acetylation of these residues on newly synthesized histones that are deposited on new DNA ( Figure 4A ). In cells lacking Hdac3, the levels of acetylation of these residues were already high and increased only modestly during S phase ( Figure 4A ). Whereas H3K9,K14 acetylation has not been linked to histone deposition in mammalian cells in the manner that H4K5ac and H4K12ac have, its levels were low in G 0 /G 1 phase control cells and increased during S phase. In the absence of Hdac3, H3K9,K14ac was not reduced upon serum starvation, suggesting that acetylation of these residues was not removed after S phase, which could account for the loss of H3K9me3 and reduced heterochromatin in Hdac3-null livers (Figures 2 and 3) . To better define the requirements for Hdac3 in the removal of cell-cycle-associated marks, we directly examined H4K5ac in S phase cells, as this is a classical deposition mark. The punctate immunofluorescence pattern of PCNA 18 hr after release from serum starvation was used to identify cells in late S phase, which are characterized by foci of PCNA at the nuclear periphery Madsen and Celis, 1985; Taddei et al., 1999) . Although a general increase in H4K5ac was observed in the absence of Hdac3 (data not shown), a pronounced increase in H4K5ac was found in late S phase cells (11% of cells in controls versus 57% of Hdac3-null cells) ( Figure 4B ), especially at the nuclear periphery.
Even relatively modest overexpression or reduced expression of histones is sufficient to affect genomic stability by causing DNA double-strand breaks (Gunjan and Verreault, 2003; Olive and Banath, 1995) . Given the apparent high level of H4K5ac in the nucleus of Hdac3-null cells after S phase (Figures 4A and  4B) , we asked what proportion of the total histone H4 is acety- Western blot analysis of nuclear extracts prepared from p17 Hdac3-null hepatocytes to examine histone acetylation and histone methylation levels. H3 and H4 served as loading controls. lated in the absence of Hdac3. Two sequential rounds of immunoprecipitation of lysates prepared from quiescent Hdac3-null NIH 3T3 cells were performed using anti-H4K5ac to identify the acetylated histone. Western blot analysis using anti-H4K5ac confirmed that most of the acetylated histone was immunopurified in the first immunoprecipitation ( Figure 4C , upper). The total histone H4 that was acetylated at K5 was then determined by comparing the amount of total histone H4 in the immunoprecipitation versus H4 that remained in the supernatant ( Figure 4C , lower). For the western blot analysis, one-fifth the amount of the supernatant was loaded as compared to the precipitated H4K5ac. Thus, roughly 15%-20% of the total histone H4 was acetylated at K5 in control cells and 30%-40% was acetylated in the absence of Hdac3 ( Figure 4C ).
Hdac3 Is Required for Genomic Stability
Previously, we noted S phase-associated DNA double-strand breaks in Hdac3-null cells . Given the requirement for Hdac3 in removing histone acetylation marks that are added during the S phase of the cell cycle and the links between loss of H3K9me3 and genomic instability, we examined the consequences of inactivation of Hdac3 to chromosomes as they progress through mitosis. Metaphase spreads were prepared from Hdac3 FL/+ and Hdac3 FL/À MEFs following either Ad-Cre infection or following tamoxifen treatment of MEFs carrying the ER-Cre transgene. Both chromosome breaks and gaps were quantified using cytogenetic analysis. Using either Ad-Cre ( Figure S4 ) or ER-Cre to delete Hdac3 ( Figure 5A ) led to a 5-to 8-fold increase in the average number of breaks and gaps in metaphase chromosomes when compared to control cells ( Figure 5B ), indicating a crucial role for Hdac3 in the maintenance of genome stability. To test whether the DNA damage and genomic instability phenotypes found in MEFs lacking Hdac3 were recapitulated in vivo, we examined Alb-Cre:Hdac3 +/À and Alb-Cre:Hdac3
livers for DNA double-strand breaks using immunofluorescence to detect gH2AX and 53BP1, which localize to sites of DNA double-strand breaks (Iwabuchi et al., 2003) . Whereas there was little or no endogenous DNA damage in Alb-Cre:Hdac3
livers at p17 (data not shown), by p28 the Hdac3-null livers displayed an increased number of cells with gH2AX and 53BP1 foci when compared to the control hepatocytes ( Figure 5C , 0 Gy panels; see Figure S4 for quantification). Subsequently, we examined DNA repair in Hdac3-null hepatocytes at p28 following a nonlethal dose of IR (3 Gy). An increased percentage of cells with a substantial amount of DNA damage was detected both 1 and 6 hr after IR in Alb-Cre:Hdac3
when compared to the control Alb-Cre:Hdac3 +/À hepatocytes ( Figure 5C ). Quantification of 53BP1 foci in $100 cells from two independent experiments following a 6 hr recovery period revealed that Hdac3-null cells have a greater percentage of cells with five to ten foci when compared to the control cells (Figure S4) . We also observed DNA damage even after a 24 hr recovery period in some Alb-Cre:Hdac3 À/À hepatocytes, whereas control hepatocytes had repaired the damage caused by IR treatment (data not shown).
Hdac3-Null Livers Develop Hepatocellular Carcinoma
Analysis of gene expression data obtained previously from AlbCre:Hdac3 À/À livers at p28 identified an upregulation of genes that belong to the p53 network ( Figure S4 ), suggesting the presence of DNA damage. Likewise, quantitative RT-PCR analysis revealed an upregulation of miRNAs regulated by p53 in Hdac3-null livers ( Figure S4 ), which is also consistent with the activation of a DNA damage response (Rokhlin et al., 2008) . In addition, hepatocellular carcinoma (HCC) progression markers, such as g-glutamyltranspeptidase1 (Pavesi et al., 1989 ) and insulin-like growth factor II (Qiu et al., 2008) , were upregulated in the microarray analysis of Alb-Cre:Hdac3 À/À livers by 2.2-and 2.7-fold, respectively . These data, coupled with the observed genomic instability, prompted us to age cohorts of 20 control and 20 Alb-Cre:Hdac3 À/À mice.
By 15-16 weeks of age, the livers were very pale due to the dramatic accumulation of neutral lipids and fat caused by inactivation of Hdac3 and contained ''white nodules'' when examined by gross morphology ( Figure 6A ). These nodules were encapsulated with a fibrous lining that positively stained with Massion's trichrome (data not shown) and appeared to be benign ''adenoma-like'' structures with the cytoplasm of the cells filled with microvesicular fluid and an abundance of mitochondria ( Figure 6A and data not shown). By 8-10 months of age, most of the mice began to show signs of distress, and necropsy identified the presence of tumors in the liver. The experiment was humanely terminated for all mice by 14 months of age ( Figure 6B ). Pathological analysis indicated that 20 of 20 mice succumbed to low-grade HCC at a mean age of 10.2 months ( Figure 6B ). Immunohistochemical staining for Hdac3 confirmed that the tumors lacked expression of Hdac3 ( Figure 6C ) and Ki67 staining confirmed a high proliferative index in the tumors ( Figure 6D ). The HCC displayed a loss of normal architecture, a trabecular patterning of cells, a lack of ductal morphology, and very disorganized features ( Figure 6D ). The loss of genomic stability and the impaired response to DNA damage suggested that a high mutation rate stimulated the development of HCC (Figures 1, 5, and 6 ). To begin to assess what pathways were involved in the formation of HCC, we performed gene expression analysis using cDNA microarrays (Figure 7A ). In the array data, we noted the enhanced expression of c-Myc, a commonly overexpressed oncogene, which was confirmed using quantitative RT-PCR ( Figure 7B ). Signatures consistent with activation of the Ras pathway and impairment of the p53 pathway were also identified in this analysis (Figure 7A) . The Wnt pathway has been identified as a key regulatory node in human HCC and we also noted that this pathway was affected in the Hdac3-null tumors. Therefore, we examined b-catenin localization using both cell fractionation and immunohistochemical staining. As early as p28, we found increased amounts of b-catenin localized to the nucleus and there was prominent nuclear localization of b-catenin in the Hdac3-null HCCs ( Figures 7B and 7C) , confirming that this oncogenic pathway was upregulated in this mouse model of HCC. NCOR1 Is Downregulated in HCC and NCOR and SMRT Regulate Global Histone Acetylation Analysis of HDAC3 mRNA levels in four independent human HCC data sets from the Gene Expression Omnibus (GEO) database indicated that HDAC3 was reduced in some cases ( Figure 8 ; Figure S5 ). HDAC3 is highly expressed in cycling cells (e.g., in the crypt regions of the colonic epithelium) (Spurling et al., 2008; Wilson et al., 2006) , so comparing quiescent normal tissue to cycling cancer cells may underestimate the level of its loss of expression. Nevertheless, in the largest data set, HDAC3 levels were reduced by 1.5-fold in 13% of the cases and over 2-fold in 3.3% of the cases as compared to normal controls (data not shown and Figure 8A ). There was no association with hepatitis C or hepatitis B viral infection or survival (data not shown). Given that HDAC3 is dormant until activated by association with NCOR or SMRT (Guenther et al., 2001 ) and that it is recruited to chromatin through association with other factors, we probed the GEO HCC data sets for changes in expression of the 57 direct interaction partners of HDAC3 identified in the Human Protein Reference Database (Table S1 ). Four of these genes (STAT3, GTF2I, GCM1, and NCOR1) showed reduced expression in HCC. NCOR1 is not only downregulated but is also located on a region of chromosome 17p that is deleted in human HCC (Xu et al., 2001) . The levels of NCOR1 were reduced by 2-fold or greater in nearly one-third of HCC samples in the largest data set ( Figure 8A ) and were similarly downregulated in the majority of the samples in smaller HCC gene expression data sets ( Figure S6 ). Using immunohistochemistry to detect nuclear NCOR1, we found that two-fifths of the human HCCs tested had reduced levels of NCOR1 ( Figure 8B ), which is consistent with the mRNA expression results.
Given that NCOR/SMRT directly control HDAC3 functions (Guenther et al., 2001 ), we used siRNAs to probe the requirements for these HDAC3 cofactors in the regulation of histone acetylation. In HeLa cells that express both family members, depletion of either NCOR or SMRT alone had only modest effects on global histone acetylation (data not shown). Targeting both family members together caused a small increase in H4K5ac ( Figure 8C ). However, even though NCOR/ SMRT levels were only reduced by about 50%, there was a significant accumulation in the levels of global H4K5ac in both HeLa cells ( Figure 8C ) and NIH 3T3 cells ( Figure S6B ). These increases in histone acetylation were associated with a decrease in the levels of HDAC3 detected in both HeLa and NIH 3T3 cells ( Figure 8C ; Figure S6C ). Immunofluorescence using anti-PCNA to identify S phase cells demonstrated a 5-fold increase in the number of cells with high levels of H4K5ac at the nuclear periphery in late S phase cells targeted with siRNAs to both cofactors ( Figure 8D ; Figure S6C ). Given this alteration in histone marks, we examined these cells for DNA double-strand breaks using anti-53BP1. Cells depleted of NCOR1 and SMRT showed a dramatic increase in the number of cells with greater than ten foci ( Figure 8E ; Figure S6D ). Collectively, these results show that the NCOR/SMRT/HDAC3 axis is required for removing histone marks globally and maintaining genomic stability. See also Figure S5 .
DISCUSSION
The increase in acetylation of H4K5, H4K12, H4K16, and H3K9,K14 that was observed upon inactivation of Hdac3, along with the concomitant loss of H3K9me3, provides a likely mechanism for the failure to maintain chromatin structure in Hdac3-null mice (Figure 2 ). H4K5ac and H4K12ac are associated with histone deposition (Sobel et al., 1995) , especially in heterochromatic regions that are replicated late in S phase (Taddei et al., 1999) , and this pattern was accentuated in the absence of Hdac3 or when NCOR/ SMRT were targeted using siRNAs (Figures 4 and 8) . The removal of these marks is required for propagation of heterochromatin in yeast (Zhou et al., 2009) , which suggests that the accumulation of these marks (and the reduced levels of H3K9me3) may be the underlying cause for the reduction in heterochromatin in the Hdac3-null livers. Indeed, loss of H3K9me3 impaired the DNA damage response, and the inactivation of the murine H3K9 methyltransferases or mutation of HP1b caused genomic instability, defects in double-strand-break repair, and an increased tumor risk (Aucott et al., 2008; Kondo et al., 2008; Luijsterburg et al., 2009; Peters et al., 2001; Sun et al., 2009 ). This suggests that the failure to maintain a normal chromatin structure underlies the Hdac3 À/À -associated defects in two distinct types of DNA repair (NHEJ and HR), and in genomic stability (Figures 1 and 5) , which ultimately led to tumor development ( Figure 6 ). The siRNA-mediated knockdown of NCOR/SMRT, like deletion of Hdac3, caused the accumulation of histone deposition marks, suggesting that these Hdac3-activating factors also play an intrinsic role during the cell cycle. NCOR and SMRT were initially identified as transcriptional corepressors associated with nuclear hormone receptors (Chen and Evans, 1995; Horlein et al., 1995; Karagianni and Wong, 2007) , as well as with a variety of DNA-binding factors (Perissi et al., 2004) . However, the function of these corepressors during the cell cycle
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Hdac3 Is Required for Genomic Stability may represent the ancestral activity of these complexes. We speculate that during evolution this cell-cycle machinery was recruited in higher organisms to regulate gene expression patterns in a cell-type-specific manner (e.g., in response to nuclear hormones) or to form heterochromatin to more permanently silence gene expression.
Although HDAC3 has been suggested to be overexpressed in colorectal carcinoma (Spurling et al., 2008; Wilson et al., 2006) , it is not amplified at the DNA level. In addition, HDAC3 is expressed at higher levels in the proliferating cells of the colonic crypts, which might suggest that its levels are higher in colorectal carcinoma because the cells are cycling. Conversely, it is notable that HDAC3 lies within a region of chromosome 5q31.3 that is frequently deleted in breast cancer (Johannsdottir et al., 2006) and myelodysplastic syndromes (Ebert, 2009) . Intriguingly, NCOR1 lies in a region of chromosome 17 that is frequently deleted in HCC (Mahlknecht et al., 1999) , and an analysis of expression profiles indicated that downregulation of NCOR1 expression is common in a subset of human HCC ( Figure 8A; Figure S6) . Our data are consistent with the inactivation of the HDAC3/NCOR/SMRT axis, possibly contributing to a subset of human cancer by allowing the increase of histone acetylation during the S phase, leading to DNA damage and further accumulation of mutations.
Nearly all nontargeted cancer therapeutics (i.e., those that do not target a mutant protein that initiates a cancer) develop a therapeutic window by acting on cycling cells to cause DNA damage (Ashwell and Zabludoff, 2008; Lieberman, 2008) . However, one side effect is that these agents, when given at too high a dose or for too long, also cause genomic instability in normal cells, leading to therapy-associated secondary cancers. Our results raise this possibility for HDIs, all of which currently target HDAC3. However, compounds such as SAHA appear to be well tolerated, possibly owing to their short half-life in vivo (Butler et al., 2000) . That is, SAHA may cause S phase-associated DNA damage for those cancer cells in S phase during the 4-6 hr window in which the daily dose of SAHA is active, but only cause mild problems for the majority of normal cells that are not cycling. In addition, normal cells that are proliferating, such as in the gastrointestinal tract and in the bone marrow, can either repair the DNA damage or their chromatin is ''reset'' after the SAHA is metabolized. Thus, we predict that although continuous inhibition of Hdac3 is detrimental (e.g., Figure 6 ), transient inhibition, even when frequently repeated, may be safe.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for additional methods used.
Mice
Mice harboring either a conditional floxed (FL) allele or a null (À) allele were created as described previously . To create liver-specific Hdac3 knockout mice, mice with a floxed or a null allele were crossed to transgenic mice expressing Alb-Cre DNA Repair Assays DNA repair assays were performed using HEK293 cells engineered with integrated reporters for both types of double-strand-break repair (Zhuang et al., 2009) . Briefly, cells (1 3 10 5 ) were transfected twice with HDAC3 siRNA using Oligofectamine (Invitrogen). pCMV-I-Sce1 or the control vector was transfected into the cells using FuGene 6 (Roche). The cells were either analyzed by two-color FACS analysis to examine homologous recombination or PCR was used to determine the rate of NHEJ-mediated repair (see Supplemental Experimental Procedures for primer sequences).
Transmission Electron Microscopy
Liver tissue was minced into fine pieces and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer at room temperature for 1-2 hr. Samples were then washed in 0.1 M cacodylate buffer and treated with 1% aqueous osmium Table S1. tetraoxide. Tissues were then washed, dehydrated, and embedded in Spurr resin. Thin sections (100 nm) were viewed with an FEI CM-12 transmission electron microscope operated at 80 KeV.
Gene Expression Analysis of Human HCC Samples
Four HCC and normal control experiments (GSE14323, GSE6764, GSE6222, and GSE5975) were selected from the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo) (Barrett et al., 2009 ). The description of this analysis is elaborated in Supplemental Experimental Procedures. For GSE6764 (Wurmbach et al., 2007) , we compared the normal liver samples with HCC samples of different stages. For GSE6222 (Liao et al., 2008) , we excluded the HuH7 cell line data. GSE1898 was excluded from this analysis due to variations in the probe sets. Expression data generated from murine tumors lacking Hdac3 are found in GSE22457.
Protein Analyses
For preparation of whole-cell protein extracts, the cell pellet was washed with PBS and sonicated in RIPA buffer (0.5% Triton X-100, 0.5% deoxycholic acid, and 0.5% SDS in PBS) with protease inhibitors (0.5 mM PMSF, 2 mg/ml leupeptin, and 15 mg/ml aprotinin) prior to western analyses. Antibodies used and the preparation of nuclear extracts are described in Supplemental Experimental Procedures. See also Figure S6 .
